US Patent Issued to MEDIFRON DBT on July 28 for "Compound having inhibitory activity against O-glusacase and use thereof" (South Korean Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,260, issued on July 28, was assigned to MEDIFRON DBT INC. (Seoul, South Korea).

"Compound having inhibitory activity against O-glusacase and use thereof" was invented by Hee Kim (Anyang-si, South Korea), Hee Jin Ha (Ansan-si, South Korea), Hye Min Ju (Gunpo-si, South Korea), Ki Sun Roh (Seoul, South Korea), Jae Hong Im (Seoul, South Korea), Jin Mi Kang (Seoul, South Korea) and Minyoung Lee (Incheon, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a novel compound having inhibitory activity against O-GlcNAcase and a use thereof."

The patent was filed on Nov. 19, 2021, under Application No. 18/037,895.

*Fo...